Maarten Van Geffen

Maarten van Geffen’s is currently responsible for the outsourced production of drug product to support the clinical development of Leiden based biopharmaceutical ProQR Therapeutics NV. Recently Maarten had a similar position supporting vaccine development for Janssen Vaccines and Prevention. Before that he had several leading CMC positions in Biotech SME’s including Vice President Quality & CMC for Amakem NV, head of CMC for Shire-Movetis, Director of CMC Regulatory Affairs at Barrier Therapeutic NV and Janssen Biologics. Before initiating his career in the industry, Mr Van Geffen was assessor of quality part pharmaceutical dossiers for the Dutch Health and Environmental agency.